Biotron Limited reported earnings results for the half year ended December 31, 2022. For the half year, the company reported net loss was AUD 0.793589 million compared to AUD 1.94 million a year ago. Basic loss per share from continuing operations was AUD 0.0011 compared to AUD 0.0028 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.052 AUD | -5.45% | -10.34% | -46.39% |
Apr. 05 | Biotron Meets Primary Objectives of Phase Two HIV Trial; Shares Surge 25% | MT |
Feb. 26 | Biotron Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-46.39% | 33.14M | |
+7.84% | 115B | |
+13.06% | 107B | |
-13.14% | 22.31B | |
-3.99% | 21.6B | |
-6.62% | 18.23B | |
-39.93% | 17.62B | |
+7.00% | 14.26B | |
+32.73% | 12.37B | |
-28.32% | 8.28B |
- Stock Market
- Equities
- BIT Stock
- News Biotron Limited
- Biotron Limited Reports Earnings Results for the Half Year Ended December 31, 2022